Research & Innovation 2016
23 March 2016
Trent Vineyard, Nottingham
European Laboratory Research & Innovation Group (ELRIG) conference directors Mike Jowett (Illumina) and Mark Wigglesworth (AstraZeneca) are very pleased to welcome you to the 4th annual Research & Innovation conference and technology symposium.
The theme of this year’s conference is “Back to Biology”. The meeting will bring together world class speakers and leading industry experts who will discuss the challenges and opportunities in developing and applying new thinking across biology to improve the success of drug discovery. The focus of this meeting will be Cell Biology and Biologics applying new innovations in these fields to improve the success of drug discovery.
This conference will have 3 tracks; the first will define new thinking in the area of biopharmaceutical agents and how this area continues to offer important alternative approaches to drug discovery. The second will focus on Stem Cell Biology and how innovations in this space are offering improved models for research. Finally a new track for this year where we bring Cell Biology and Biologics crashing together in Synthetic Biology: Engineering complex biological systems. Following the success of previous meetings we are expanding the conference this year to include a complementary technology symposium: Innovative Mass Spectrometry.
The objective of this 1 day conference is to provide a communication, education and networking opportunity for scientists engaged in early-phase drug discovery whether in academia, biotech or industry. This conference will bring world class speakers discussing challenges and opportunities in developing new technologies and the way different organisations meet this challenge by bringing their scientists together.
The Research and Innovation tracks are:
Biopharmaceutical Agents: Innovations from Target to Product
Stem Cell Biology: A Roadmap for a Moving Landscape
Synthetic Biology: Engineering complex biological systems
Technology Symposium track:
Innovative Mass Spectrometry: Cornerstone technology for the “omics” revolution
These scientific sessions have been chosen as they represent major transformative areas for early stage drug discovery. The scientific sessions will be complemented by a poster session, a vendor exhibition and an Innovation zone.
The 4th Annual Research & Innovation Meeting recently held in Nottingham UK was a great success! With more than 250 delegates registered – Trent Vineyard was buzzing with activity.
Delegates enjoyed a meeting programme packed with presentations highlighting ground breaking research and newly published or cutting-edge unpublished data. Kicking off the day was an inspiring Plenary Keynote presentation by Steven Ward of Cell Therapy Catapult on the topic of Overcoming the Manufacturing Commercialisation Challenges for Cell and Gene Therapy. The scientific tracks covered in this year’s meeting were Stem Cell Biology, Synthetic Biology and Biopharmaceuticals and also included a technology symposium on Mass Spectrometry.
The world-class lineup of speakers from both academia and pharma was complemented by 28 poster presentations. The conference directors selected several posters of extremely high quality for short presentations during the main scientific sessions. Dr. Marko Stoch, won the award for best poster with his poster entitled, “Basic – A Novel DNA Assembly Method for Optimizing Pathways & Genetic Circuits.2
Exhibitors and Snapshot Sessions:
26 companies exhibited at the event, with 4 up-and-coming companies participating in our Innovation Zone. Many companies selected this venue to showcase their newest technology platforms and product offerings, and as a reward, 8 companies were selected by the scientific committee to give 5 min “Snapshot Presentations” during each of the scientific sessions to discuss their enabling technologies, products or services. Delegates voted for their favourite new technology and awarded the prize to LabLogic for the second year in a row for their Multi-Technology Microplate Reader.
Conference directors Mark Wigglesworth (AstraZeneca) and Mike Jowett (Horizon Discovery) were thrilled that the conference achieved one of the main objectives of the ELRIG organisation –that is to make excellent scientific content freely accessible to an ever increasing number of delegates from a diverse range of scientific disciplines and backgrounds.
Research & Innovation 2016 – Back to Biology
A warm thank you to all our speakers who volunteered their time as well as the tireless efforts of the scientific committee in putting together an amazing scientific programme:
- Jonathan Wingfield, AstraZeneca
- Davide Danovi, King’s College London
- Julie Holder, Roslin Cells
- Murray Brown, GlaxoSmithKline
- Geoff Baldwin, Imperial College London
- Gary Pettman, MedImmune
- David Krige, Immunocore
Look out for more information on Research & Innovation 2017 at our 10th Anniversary Drug Discovery meeting in October 2016.